144 ·Filed Aug 7, 2026

BLCO

Bausch & Lomb Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago SEC0001957799-26-000148
Actionable Insight • Neutral

Monitor for actual execution of the sale on Form 4. Given the small size and former director status, no material price impact is expected. The filing does not signal any change in company fundamentals.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
BLCO ▲ +5.35% at T+20d
NEUTRAL call ✓ call won +5.35% · α vs SPY +6.26% · entry $16.83 → $17.73
Next anchor: T+60d in 4w
Latest observation: T+36 +4.50% FF3 residual α
Entry anchored
Aug 7, 04:00 PM ET
via 1-min bar
T+1d
+0.24%
call +0.24% · α +0.56%
$16.87
settled 8w ago
T+5d
+1.01%
call +1.01% · α +1.06%
$17.00
settled 7w ago
T+20d
+5.35%
call +5.35% · α +6.26%
$17.73
settled 28d ago
T+60d
—
call — · α —
—
in 4w

Price Chart

Loading chart...

Executive Summary

Former director Andrew C. Von Eschenbach filed a Form 144 notice of intent to sell 12,500 shares of Bausch & Lomb Corp common stock, valued at approximately $206,193. The shares were acquired through open market purchases in 2025 and 2026. The sale is small relative to BLCO's $5.8B market cap and represents routine portfolio diversification by a former board member.

Key Facts

  • Former director Andrew C. Von Eschenbach intends to sell 12,500 shares of BLCO common stock.
  • Estimated market value of the proposed sale is $206,192.77.
  • Shares were acquired via open market purchases on 05/02/2025 (1,695 shares) and 02/27/2026 (4,364 shares).
  • The filing is a notice of intent, not a completed sale; the sale may or may not occur.
  • The sale represents approximately 0.0035% of BLCO's $5.8B market cap.

Financial Impact

Proposed sale of 12,500 shares valued at ~$206K, negligible relative to $5.8B market cap.

dilution

Risk Factors

  • Insider selling, even small, may be perceived negatively by some market participants.
  • No additional context from other filings to suggest broader insider sentiment.

Market Snapshot

Exchange
NYSE
Sector
Ophthalmic Goods
Analyst Consensus
56% bullish (18 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (BLCO) — Batch item 10001957799-26-000148
Document: 0001957799-26-000148-index.html0001957799-26-000148
Document: 0001957799-26-000148.txt0001957799-26-000148
144 Filing (BLCO) — Batch item 40001957799-26-000148
Document: 0001957799-26-000148-index.html0001957799-26-000148
Document: 0001957799-26-000148.txt0001957799-26-000148
16 reports for BLCO
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+20▲ +6.48%Jul 29, 2026
Filters
Rows
Reports for BLCO — sortable, filterable
TypeNow
Aug 14, 2026
7w ago
3 / CLUSTER
NEUTRAL ★ 2/10
$17.00 $17.23▲ +1.35%▲ +3.33%$17.11 (+0.65%)
Aug 14, 2026
7w ago
3
NEUTRAL ★ 2/10
$17.00 $17.23▲ +1.35%▲ +3.33%$17.11 (+0.65%)
Aug 14, 2026
7w ago
3
NEUTRAL ★ 2/10
$17.00 $17.23▲ +1.35%▲ +3.33%$17.11 (+0.65%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$16.98 $17.25▲ +1.59%▲ +3.34%$17.11 (+0.77%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$16.98 $17.25▲ +1.59%▲ +3.34%$17.11 (+0.77%)
Aug 7, 2026
8w ago
144
NEUTRAL ★ 2/10
$16.83 $17.73▲ +5.35%▲ +6.26%$17.11 (+1.66%)
Aug 6, 2026
8w ago
144
NEUTRAL ★ 2/10
$16.35 $18.14▲ +10.95%▲ +10.35%$17.11 (+4.65%)
Aug 6, 2026
8w ago
8-K
MIXED ★ 5/10
$16.35 $18.14▲ +10.95%▲ +10.35%$17.11 (+4.65%)
Jul 29, 2026
9w ago
8-K
BULLISH ★ 6/10
$16.20 $17.25▲ +6.48%▲ +1.46%$17.11 (+5.62%)
Feb 27, 2026
31w ago
Insider Cluster
BULLISH ★ 7/10
$18.30 $15.37▼ −16.01%▼ −8.45%$17.11 (−6.50%)
Showing 10 of 16

US Market Status

Market Closed — Opens Mon (38h 38m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access